- Home
- BCIC vs COYA Comparison
BCIC vs COYA Comparison
Compare BCIC & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCIC | COYA |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6M | 102.7M |
| IPO Year | 2006 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BCIC | COYA |
|---|---|---|
| Price | $5.97 | $4.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $9.83 | ★ $15.21 |
| AVG Volume (30 Days) | 32.3K | ★ 129.2K |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | ★ 17.68% | N/A |
| EPS Growth | ★ 262.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,945,753.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $387.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $6.33 | $3.71 |
| 52 Week High | $13.50 | $7.50 |
Technical Indicators
Market Signals| Indicator | BCIC | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 19.05 | 33.95 |
| Support Level | N/A | $3.89 |
| Resistance Level | $7.57 | $5.17 |
| Average True Range (ATR) | 0.18 | 0.27 |
| MACD | -0.07 | -0.08 |
| Stochastic Oscillator | 0.87 | 1.99 |
Price Performance
Historical ComparisonAbout BCIC BCP Investment Corporation
BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.